Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.
Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' expanded melanoma panel can enhance patient care. The updated assay provides more comprehensive genomic coverage to better classify melanoma tumors and guide treatment decisions.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:32)
Could you provide a little bit of background about yourself?
(01:43)
Could you give a brief overview of the new melanoma assay?
(04:53)
Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications?
(05:12)
Could you talk a little more about the MSI assessment in this panel?
(05:59)
Which patients should have this testing?
(07:01)
How are these results used in patient care?
(08:39)
Is there anything else you'd like to add?